Pachymic acid alleviates circadian rhythm disorders in high-fat diet-induced obesity mice via the sphingolipid pathway
PLOS One · 01.07.2026 · 21 (7) · e0352604
DOI: 10.1371/journal.pone.0352604 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 01.07.2026. Verfasst von Hong Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China. Hauptthemen laut MEDLINE: Diet, High-Fat, Obesity, Triterpenes, Sphingolipids. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Province Science and Technology Support Program.
Abstract (Originalsprache)
Background
Obesity caused by a high-fat diet (HFD) is known to disrupt metabolic homeostasis and circadian rhythms. Pachymic acid (PA), a bioactive triterpenoid, exhibits anti-inflammatory, antihyperglycemic, antihyperlipidemic, and sedative-hypnotic properties, though its role in circadian regulation remains unexplored.
Methods
We assessed PA’s impact on metabolic dysfunction (glucose/lipid profiles), systemic inflammation using biochemical assays, ELISA, Oil Red O staining. Circadian parameters were evaluated via 24-h serum melatonin and core body temperature. Hepatic circadian gene oscillations and mechanistic pathways were analyzed through time-series RNA sequencing, bioinformatics, qPCR, and Western blotting.
Results
PA intervention attenuated obesity-related phenotypes, including reduced body weight, improved glucose/lipid metabolism, and restored physiological rhythms of melatonin and body temperature. And hepatic gene oscillation patterns were realigned to circadian synchrony. Mechanistically, PA ameliorated liver inflammation by modulating the sphingolipid pathway, specifically via S1PR4/TRAF2 signaling.
Conclusions
Our findings illustrate PA’s role in mitigating metabolic and circadian disruptions in obesity, highlighting the sphingolipid pathway as a tissue-specific target for circadian modulation. This study provides novel insights into therapeutic strategies for obesity-associated circadian disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Department of Orthopedics, Chengdu Integrated Traditional Chinese Medicine & Western Medicine Hospital/Chengdu First People's Hospital, Chengdu, China.
ORCID-Profile: Hong Yang, Weijun Ding
Förderung
- National Natural Science Foundation of China
- Sichuan Province Science and Technology Support Program
Zitieren
APA
Yang, H., Mei, Y., Chen, J., Chen, J., Zhu, J., Zhang, L., Gong, Y., Luo, G., & Ding, W. (2026). Pachymic acid alleviates circadian rhythm disorders in high-fat diet-induced obesity mice via the sphingolipid pathway. PLOS One, 21(7), e0352604. https://doi.org/10.1371/journal.pone.0352604
Vancouver
Yang H, Mei Y, Chen J, Chen J, Zhu J, Zhang L, et al. Pachymic acid alleviates circadian rhythm disorders in high-fat diet-induced obesity mice via the sphingolipid pathway. PLOS One. 2026;21(7):e0352604. doi:10.1371/journal.pone.0352604
BibTeX
@article{Yang2026,
author = {Yang, Hong and Mei, Yingxiu and Chen, Jilan and Chen, Jiawei and Zhu, Jiushuang and Zhang, Lu and Gong, Yanju and Luo, Gan and Ding, Weijun},
title = {Pachymic acid alleviates circadian rhythm disorders in high-fat diet-induced obesity mice via the sphingolipid pathway},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {7},
pages = {e0352604},
doi = {10.1371/journal.pone.0352604}
}
EUVIMED